SPL 1.02% 9.9¢ starpharma holdings limited

New indications for irinotecan, page-10

  1. 3,506 Posts.
    lightbulb Created with Sketch. 836
    @juxtaposer this statement of yours (and of @antibotter ) below is misleading and should be considered to be without foundation and untrue unless you can back it up with a link/reference.

    “The source of “Starpharma’s DEP Irinotecan combination cancer drug has shown to be superior to Onivyde” comes from research and presentations by Starpharma itself.”


    Last edited by sarge17: 02/06/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.001(1.02%)
Mkt cap ! $41.39M
Open High Low Value Volume
9.8¢ 10.0¢ 9.8¢ $28.58K 288.8K

Buyers (Bids)

No. Vol. Price($)
1 59999 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 1252 1
View Market Depth
Last trade - 16.10pm 07/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.